CABA
Cabaletta Bio, Inc.NASDAQHealthcare$2.96+1.69%ClosedMarket Cap: $284.9M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
2.75
P/S
0.00
EV/EBITDA
-1.36
DCF Value
$0.49
FCF Yield
-45.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-121.7%
ROA
-101.7%
ROIC
-123.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | Infinity% | $-42.6M | $-41.9M | $-0.41 | — |
| FY 2025 | $0.00 | -Infinity% | $-172.2M | $-167.9M | $-1.64 | — |
| Q3 2025 | $0.00 | -Infinity% | $-46.6M | $-44.9M | $-0.44 | — |
| Q2 2025 | $0.00 | -Infinity% | $-45.9M | $-45.1M | $-0.73 | — |
| Q1 2025 | $0.00 | -Infinity% | $-37.1M | $-35.9M | $-0.73 | — |
| Q4 2024 | $0.00 | -Infinity% | $-33.8M | $-32.6M | $-0.65 | — |
| FY 2024 | $0.00 | -Infinity% | $-125.1M | $-115.9M | $-2.34 | — |
| Q3 2024 | $0.00 | -Infinity% | $-33.0M | $-30.6M | $-0.62 | — |
| Q2 2024 | $0.00 | NaN% | $-30.3M | $-27.6M | $-0.56 | — |
| Q1 2024 | $0.00 | -Infinity% | $-28.0M | $-25.0M | $-0.51 | — |
| Q4 2023 | $0.00 | -Infinity% | $-23.1M | $-20.9M | $-0.47 | — |
| FY 2023 | $0.00 | -Infinity% | $-74.7M | $-67.7M | $-1.65 | — |